Pure Global
Turkey ÜTS registration 4007bc9b3d3b9b1a181c0c2a6a1ff855

READY-TO-USE SYRINGE CONTAINING EVENITY 105 MG/1.17 ML SOLUTION FOR INJECTION, 2 PCS

TR: EVENİTY 105 MG/1,17 ML ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR ENJEKTÖR, 2 ADET
Turkey flagTurkey·Pharmaceutical Product·AMGEN İLAÇ TİC. LTD. ŞTİ.·Licensed Mar 08, 2022
License details
Product ID (UID)
4007bc9b3d3b9b1a181c0c2a6a1ff855
License Number
2022/104
Barcode
8699862950244
ATC Code
M05BX06
License holder information
License Holder
AMGEN İLAÇ TİC. LTD. ŞTİ.
Active ingredient & license information
Active Ingredient (EN)
Romosozumab
License Date
Mar 08, 2022
About this record

Access comprehensive regulatory information for READY-TO-USE SYRINGE CONTAINING EVENITY 105 MG/1.17 ML SOLUTION FOR INJECTION, 2 PCS in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 4007bc9b3d3b9b1a181c0c2a6a1ff855 with license number 2022/104and contains active ingredient Romosozumab . The license is held by AMGEN İLAÇ TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI21,000+ Products